Madrigal Pharmaceuticals
MDGL
MDGL
148 hedge funds and large institutions have $2.27B invested in Madrigal Pharmaceuticals in 2018 Q2 according to their latest regulatory filings, with 63 funds opening new positions, 47 increasing their positions, 34 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
148
Holders Change
+48
Holders Change %
+48%
% of All Funds
3.39%
Holding in Top 10
6
Holding in Top 10 Change
+6
Holding in Top 10 Change %
%
% of All Funds
0.14%
New
63
Increased
47
Reduced
34
Closed
14
Calls
$55.4M
Puts
$8.65M
Net Calls
+$46.8M
Net Calls Change
+$46.8M
Top Buyers
Top Sellers
| 1 |
Adage Capital Partners
Boston,
Massachusetts
|
$14M |
| 2 |
Citadel Advisors
Miami,
Florida
|
$3.21M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
$17.8M |
| 4 |
Invesco
Atlanta,
Georgia
|
$610K |
| 5 |
State Street
Boston,
Massachusetts
|
$95.8M |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
AC
151
Armistice Capital
New York
| – | -$11.9M | -102,000 | Closed |
|
152
Hudson Bay Capital Management
Stamford,
Connecticut
| – | -$5.26M | -45,000 | Closed |
|
153
Point72 Asset Management
Stamford,
Connecticut
| – | -$4.66M | -39,900 | Closed |
|
|
NC
154
Nexthera Capital
New York
| – | -$4.23M | -36,226 | Closed |
|
|
PE
155
Point72 Europe
London,
United Kingdom
| – | -$1.04M | -8,900 | Closed |
|
|
JGC
156
J. Goldman & Co
New York
| – | -$529K | -4,528 | Closed |
|
|
CC
157
Caxton Corporation
Princeton,
New Jersey
| – | -$233K | -1,999 | Closed |
|
|
AIM
158
Assured Investment Management
New York
| – | -$93K | -799 | Closed |
|
|
QT
159
Quantbot Technologies
New York
| – | -$63K | -541 | Closed |
|
|
SPIA
160
Steward Partners Investment Advisory
New York
| – | -$19K | -171 | Closed |
|
|
IIC
161
Integrated Investment Consultants
Bloomfield Hills,
Michigan
| – | -$7K | -57 | Closed |
|
162
CAPTRUST Financial Advisors
Raleigh,
North Carolina
| – | -$4K | -41 | Closed |
|